Doxepin hydrochloride NDC 72205-052

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-052Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0052Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72205-052-05	72205005205	500 TABLET in 1 BOTTLE (72205-052-05)Marketed from Apr 5, 2023
72205-052-30	72205005230	30 TABLET in 1 BOTTLE (72205-052-30)Marketed from Apr 5, 2023
72205-052-91	72205005291	100 TABLET in 1 BOTTLE (72205-052-91)Marketed from Apr 5, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxepin hydrochloride
Generic name (nonproprietary): doxepin hydrochloride
Active ingredients: Doxepin hydrochloride — 3 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Novadoz Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214823
Marketing start: Apr 3, 2023
Listing expires: Dec 31, 2027
Identifiers: Product ID 72205-052_da77c05e-0081-4f48-b3cf-2a378739a968SPL ID da77c05e-0081-4f48-b3cf-2a378739a968SPL set ID 96086fd8-8fa3-4a2b-ac12-fe1a3ad4f384RxCUI 966787, 966793UNII 3U9A0FE9N5UPC 0372205052918, 0372205053304, 0372205052307, 0372205052055, 0372205053052, 0372205053915
Pharmacologic class: Tricyclic Antidepressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205005205 followed by a unit qualifier and the quantity

Package 72205-0052-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 23, 2026.

Indications (excerpt from the label)

Doxepin tablets are indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. The clinical trials performed in support of efficacy were up to 3 months in duration. Doxepin tablets are indicated for the treatment of insomnia characterized by difficulties with sleep maintenance. ( 1 , 14 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214823

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214823
Product	Strength	Form · route	Labeler	Product NDC
Doxepin hydrochloride	Doxepin hydrochloride 6 mg/1	TabletOral	REMEDYREPACK INC.	70518-4297
Doxepin hydrochloride	Doxepin hydrochloride 3 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-811
Doxepin hydrochloride	Doxepin hydrochloride 6 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-812
Doxepin hydrochloride	Doxepin hydrochloride 6 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-053